Eric J Ende's Net Worth

$4.9 Million

Estimate Recalculated Apr 10, 2025 08:46PM EST

Who is Eric J Ende

Eric J Ende has an estimated net worth of $4.9 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Matinas BioPharma Holdings, Inc., AVADEL PHARMACEUTICALS PLC, NeuBase Therapeutics, Inc., and PROGENICS PHARMACEUTICALS INC.

SEC CIK

Eric J Ende's CIK is 0001494386

Past Insider Trading and Trends

2019 was Eric J Ende's most active year for acquiring shares with 12 total transactions. Eric J Ende's most active month to acquire stocks was the month of July. 2011 was Eric J Ende's most active year for disposing of shares, totalling 3 transactions. Eric J Ende's most active month to dispose stocks was the month of March. 2017 saw Eric J Ende paying a total of $876,000.00 for 562,201 shares, this is the most they've acquired in one year. In 2011 Eric J Ende cashed out on 11,875 shares for a total of $542,830.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENZYME CORP

Investor
Updated Apr 06, 2011
Form 4
-100.00%
-9.50K
$62.76
-$542.83K
Apr 06, 2011
Options
Apr 04
Form 4
9.50K
$51.52
$367.08K
Jun 18, 2010
9.50K
Grant
Jun 16
Form 3
Jun 18, 2010
Showing 3 results

Matinas BioPharma Holdings, Inc.

Investor
Updated Nov 03, 2023
Form 4
437.24K
Nov 03, 2023
437.24K
Grant
Nov 01
Form 4
142.66K
Nov 16, 2022
142.66K
Grant
Nov 14
Form 4
90.88K
Nov 02, 2021
90.88K
Grant
Nov 01
Form 4
24.97%
28.79K
Jun 24, 2021
144.09K
Options
Jun 19
Form 4
122.61K
Nov 10, 2020
122.61K
Grant
Nov 02
Form 4
3.22%
3.60K
Jun 24, 2020
115.29K
Acquisition
Jun 23
Form 4
100.48%
109.82K
Nov 05, 2019
219.11K
Acquisition
Jun 21 - Nov 01
Form 4
22.40%
20.00K
$0.66
$13.20K
Aug 22, 2019
109.29K
Purchase
Aug 20
Form 4
28.86%
20.00K
$0.68
$13.65K
Aug 21, 2019
89.29K
Purchase
Aug 19
Form 4/A
12.20K
Apr 03, 2019
12.20K
Grant
Apr 03
Form 4
35.71%
15.02K
Jan 04, 2019
57.09K
Grant
Dec 31
Form 4
256.60K
Nov 05, 2018
256.60K
Grant
Nov 01
Form 4
30.03%
9.71K
Oct 03, 2018
42.07K
Grant
Oct 01
Form 4
175.12%
20.59K
Jul 11, 2018
32.35K
Grant
Jun 29
Form 4
12.00
$1,000.00
$12.00K
Jun 22, 2018
12.00
Purchase
Jun 21
Form 4
11.76K
Apr 02, 2018
11.76K
Grant
Mar 30
Form 4
250.00K
Feb 27, 2018
250.00K
Grant
Dec 14
Form 4/A
150.00K
$2.92
$438.00K
Jul 19, 2017
150.00K
Grant
Apr 03
Form 4
150.00K
$2.92
$438.00K
Apr 21, 2017
150.00K
Grant
Apr 03
Form 3
Apr 21, 2017
Showing 20 results

AVADEL PHARMACEUTICALS PLC

Investor
Updated Aug 01, 2024
Form 4
13.10%
22.00K
Aug 01, 2024
189.90K
Grant
Jul 30
Form 4
33.00K
Aug 03, 2023
33.00K
Grant
Aug 01
Form 4
8.39%
13.00K
$13.93
$181.10K
May 19, 2023
167.90K
Purchase
May 18
Form 4
14.83%
20.00K
$7.80
$156.05K
Nov 23, 2022
154.90K
Purchase
Nov 22
Form 4
42.00K
Aug 05, 2022
42.00K
Grant
Aug 03
Form 4
35.04%
35.00K
$2.23
$77.89K
Jun 01, 2022
134.90K
Purchase
May 31 - Jun 01
Form 4
17.67%
15.00K
$2.45
$36.75K
May 31, 2022
99.90K
Purchase
May 27
Form 4
42.00K
Aug 05, 2021
42.00K
Grant
Aug 03
Form 4
25.04%
17.00K
$5.79
$98.38K
Sep 18, 2020
84.90K
Purchase
Sep 17
Form 4
7.95%
5.00K
$7.79
$38.93K
Aug 17, 2020
67.90K
Purchase
Aug 13
Form 4
31.32%
15.00K
$7.76
$116.36K
Aug 13, 2020
62.90K
Purchase
Aug 12
Form 4
42.00K
Aug 11, 2020
42.00K
Grant
Aug 07
Form 4
26.39%
10.00K
$5.97
$59.70K
Dec 05, 2019
47.90K
Purchase
Dec 04
Form 4
35.84%
10.00K
$4.98
$49.76K
Nov 19, 2019
105.96K
Purchase
Nov 15
Form 4
60.00K
Aug 09, 2019
95.96K
Grant
Aug 07
Form 4
35.96K
May 24, 2019
35.96K
Grant
Jan 31 - May 22
Form 4
27.90K
Feb 04, 2019
27.90K
Grant
Jan 31
Form 3
Jan 03, 2019
Showing 18 results

NeuBase Therapeutics, Inc.

Investor
Updated Sep 12, 2022
Form 4
37.60K
Sep 12, 2022
37.60K
Grant
Sep 09
Form 4
165.80K
Jan 05, 2022
165.80K
Grant
Jan 01
Form 3
Jan 05, 2022
Showing 3 results

PROGENICS PHARMACEUTICALS INC

Investor
Updated Jun 23, 2020
Form 4
-100.00%
-56.39K
Jun 23, 2020
Disposition
Jun 19
Form 4
16.39K
Dec 17, 2019
16.39K
Grant
Dec 13
Form 4
40.00K
Dec 17, 2019
40.00K
Grant
Dec 13
Form 3
Sep 27, 2019
Showing 4 results